American Medical Association
FDANonrulemakingFDA-2016-D-1233

Use of Public Human Genetic Variant Databases to Support Clinical Validity for Next Generation Sequencing (NGS)-Based In Vitro Diagnostics; Draft Guidance for Stakeholders and Food and Drug Administration Staff; Availability

RIN
Last modified
Apr 17, 2018
Comment window
closed 3582d ago
American Medical Association filings
1

Activity

American Medical Association filed 1 comment on this docket between Oct 18, 2016 and Oct 18, 2016. 15 other organizations filed here. The comment window closed 3582d ago.

What American Medical Association filed (1)

Oct 18, 2016· Comment from American Medical Association· FDA-2016-D-1233-0028

Filed on regulations.gov — full text not in the inline record.

Abstract

No abstract recorded.

View on regulations.gov →
Use of Public Human Genetic Variant Databases to Support Clinical Validity for Next Generation Sequencing (NGS)-Based In Vitro Diagnostics; Draft Guidance for Stakeholders and Food and Drug Administration Staff; Availability (FDA) — American Medical Association | OpenPolis